676138-35-5

Basic information

• Product Name: Carbamic acid, [(1S,2R)-3-[[1-(3-bromophenyl)cyclohexyl]amino]-1-[(3,5-difluorophenyl) methyl]-2-hydroxypropyl]-, 1,1-dimethylethyl ester
• CAS NO: 676138-35-5
• Molecular Formula: C27H35BrF2N2O3
• Molecular Weight: 553.487
• Mol File: 676138-35-5.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: Carbamic acid, [(1S,2R)-3-[[1-(3-bromophenyl)cyclohexyl]amino]-1-[(3,5-difluorophenyl) methyl]-2-hydroxypropyl]-, 1,1-dimethylethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Carbamic acid, [(1S,2R)-3-[[1-(3-bromophenyl)cyclohexyl]amino]-1-[(3,5-difluorophenyl) methyl]-2-hydroxypropyl]-, 1,1-dimethylethyl ester(676138-35-5)
• EPA Substance Registry System: Carbamic acid, [(1S,2R)-3-[[1-(3-bromophenyl)cyclohexyl]amino]-1-[(3,5-difluorophenyl) methyl]-2-hydroxypropyl]-, 1,1-dimethylethyl ester(676138-35-5)

Safety Data

• Hazardous Substances Data: 676138-35-5(Hazardous Substances Data)

Upstream product

• 388071-27-0 tert-butyl (1S)-2-(3,5-difluorophenyl)-1-[(2S)-oxiranyl]ethylcarbamate 
• 676135-77-6 1-(3-bromo-phenyl)-cyclohexylamine 

Relevant articles and documents

METHODS OF TREATMENT OF AMYLOIDOSIS USING ASPARTYL-PROTEASE INHIBITORS

The invention relates to acetyl 2-hydroxy-1,3-diaminospirocyclohexanes and derivatives thereof that are useful in treating diseases, disorders, and conditions associated with amyloidosis. Amyloidosis refers to a collection of diseases, disorders, and conditions associated with abnormal deposition of A-beta protein.